Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival - Wikidata - awgldk - TriplyDB

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

http://www.wikidata.org/entity/Q36602163

about

Major Histocompatibility Complex I Expression by Motor Neurons and Its Implication in Amyotrophic Lateral Sclerosis Central Nervous System-Peripheral Immune System Dialogue in Neurological Disorders: Possible Application of Neuroimmunology in Urology Neuroinflammation in motor neuron disease Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?The dopaminergic system in autoimmune diseases Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging Emerging mechanisms of molecular pathology in ALS What causes amyotrophic lateral sclerosis?Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1G93A mouse model of amyotrophic lateral sclerosis.The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype.TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis.Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis.Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis.Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.Death Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis.Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis Humoral factors in ALS patients during disease progression.Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.Th17 Cell Response in SOD1G93A Mice following Motor Nerve Injury Neurovascular unit in chronic pain.Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis.Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis.Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis.ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity.Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.The multifaceted role of glial cells in amyotrophic lateral sclerosis.Glial cells in amyotrophic lateral sclerosis Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective.T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases.Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease.Inflammatory role of dendritic cells in Amyotrophic Lateral Sclerosis revealed by an analysis of patients' peripheral blood.Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis.Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers.Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial.Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson's Disease and Amyotrophic Lateral Sclerosis.

P2860

Q26744608-219CC11D-BC2D-4B5C-A298-EBF064159904 Q26745684-168C9136-43ED-4EB4-B6B7-CCC56530D413 Q26776339-DF2E0BD3-8B79-4D33-BAB8-D01E5FC580BC Q26823418-D4761921-897C-4E3B-8830-CE1C089CEF43 Q26861263-BC845D7F-6912-4603-A27E-77C266CFFAE1 Q27023885-D2C611B2-EF5C-4919-84EA-DDBDA2EF3146 Q28077869-E492A6D2-2E9A-41C9-9213-E54BF1F184F4 Q28081239-B9B96992-688C-4975-89F3-387D28C879D6 Q30234813-DBED6E4C-5D05-4D06-ACC1-157B0F4C832B Q30811549-44D17695-2DEC-4798-840D-2112D948723E Q33756216-29E51C94-AEAB-44A8-AA35-2B2BA1B154D0 Q34402056-35C567EF-DDFF-44E5-AA8B-25F026BE75A6 Q34979308-24899251-6A7E-4AE8-A61F-68A2982FE3A9 Q35064952-AC461DE5-27C6-4593-917E-7A577FB6FC26 Q35068792-FBE5D89C-1CB3-4A0D-85A9-C7D472F4A28D Q35176619-5AB9D99D-9234-40F7-87F0-B310720A4F88 Q35451557-EAFFF247-50A7-4D15-B61B-FF74880ECC81 Q35501874-796B9D50-05AE-4730-A8FC-FF5EF4B87E25 Q35623419-C3808241-8BBE-4593-A444-FBEC431A9326 Q35665302-0ED05E1B-FD19-43B7-8D6D-1FB1C5EE0DED Q35806256-E8AAA6CD-1BF4-4453-BD73-1E1A7FE57CA5 Q36474039-4A255844-E172-438D-AF58-3A4DEA02CE65 Q36855551-FEA0681C-1F12-4220-B2FF-CC958CCD641F Q36942721-3568B5B9-6D11-4A9E-BD21-83225B7B4680 Q36981080-0E362008-C4CE-4643-A73F-541D2ABC977E Q37322677-F4EB25B3-0D1E-4551-A9FE-1BE8461A02C9 Q37363769-4AFE5CB5-0270-4D9C-87C0-CA8F8858FDD6 Q37677431-AA1D072F-9826-438D-9BBE-8AD399528853 Q38123758-D9A6CB46-72D8-4AEC-B9D3-5C1C3AF7F949 Q38126396-3B837FE0-7B17-4F9B-9EE5-3ADAAC55098A Q38214532-35E4D7F3-F5A2-4043-999E-66EB9E3D0E9A Q38262690-2746CFC9-E2AA-4794-B53C-4E2D04BB1C88 Q38274179-05559579-D91A-423E-823E-B80AA38B2004 Q38341972-F9291C3A-714E-4CF7-AB4E-F80C3DEEED2A Q38543215-7353A09C-EA3D-4169-A78B-311727A8CCA0 Q38629714-C4F97813-7C0C-49AB-A8F2-D41037325004 Q38662119-805B1676-BFD5-44DC-AD49-0F3C3371BFA5 Q38701186-2991F187-F475-43AD-B380-BA86213559B0 Q38709455-6F40416C-C80B-44D8-8E8F-51F9C1ED3F0E Q38728605-BE8FF6BC-A6AB-45E6-AD9A-F329BB4B6925

P2860

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

http://www.wikidata.org/entity/Q36602163

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

@ast

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

@en

type

label

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

@ast

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

@en

prefLabel

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

@ast

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

@en

P1433

Q36602163-ED4B6C50-C9B5-4277-8238-51B0D91C4BFA

P1476

Q36602163-9317ADE6-7A33-4F29-AA18-1AEC1F063233

P2093

Q36602163-15BB0517-832A-4B28-A022-CD49832A8777

Q36602163-37CB56A9-F916-4B26-AFDA-2172140B37D4

Q36602163-476813E9-AFB1-44BF-895A-32F8CD5D17E9

Q36602163-47C13B44-AD18-470D-94CB-73E09A28B82F

Q36602163-8BA8C8D1-C94C-4177-B033-B3F74D75460C

Q36602163-B074F158-5520-4421-9CC9-9CB3ADCD117C

Q36602163-B82F6C9F-023F-447C-BD62-F2EE0561EC8F

Q36602163-D5E34ACA-5E4B-4C9A-AE01-035A9B264CB6

Q36602163-FE1C4FFE-9627-45BC-93B8-F00B968E5907

P2860

Q36602163-0B3E17B6-0D52-4942-994B-B6A185296828

Q36602163-0C70247F-097B-445C-A72F-D02A9753EAC5

Q36602163-112A72BC-3BBF-4DB5-A585-F1F3E821B041

Q36602163-18CCD90B-F414-4903-A61F-C32E5B65BB84

Q36602163-19FB6136-0B7B-4D92-8276-47D4E3E12F70

Q36602163-1B666830-D20B-4F15-B24E-EBE719630B10

Q36602163-1B9FE423-2E88-405E-8E3C-EA27C8034F4B

Q36602163-1D178A5F-3F99-421E-8E47-4A42CE093A80

Q36602163-1F555D5D-4DCA-4AB9-B7F1-C9A47F234D76

Q36602163-2E2CE675-EEB1-4D2C-A823-FF0268EAB3EE

P304

Q36602163-0C18AAA1-8446-47A3-AC97-1C898C0A4AA1

P31

Q36602163-27EB0246-ED2B-4369-85FF-FE6380618CD9

P356

Q36602163-37838FD7-2AEC-4ED4-B9E4-BC59CE5E63FD

P433

Q36602163-7B66D515-B239-4B54-88C4-610EB4A0143D

P478

Q36602163-D2D135D4-486D-49F2-8B89-FA1C81DFC38B

P50

Q36602163-749617A6-2810-4162-846A-08F0CF103628

P577

Q36602163-CC3E4CFC-2BA5-401A-BE09-3307EC00CAC6

P5875

Q36602163-3FB17AAF-6264-4417-8F71-26F2BB593BC9

P698

Q36602163-C98A8175-CE91-4D44-9488-78F9220E475A

P921

Q36602163-AB8399AA-9E62-468F-BD10-15271D900AFC

P932

Q36602163-F22A2987-CBF6-47AF-BC69-7CCBC1382A1D

P356

P1433

EMBO Molecular Medicine

P1476

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

@en

P2093

Andreana L Rivera

http://www.w3.org/2001/XMLSchema#string

Dan H Moore

http://www.w3.org/2001/XMLSchema#string

David R Beers

http://www.w3.org/2001/XMLSchema#string

Jenny S Henkel

http://www.w3.org/2001/XMLSchema#string

Joan E Appel

http://www.w3.org/2001/XMLSchema#string

Karen M Toennis

http://www.w3.org/2001/XMLSchema#string

Shixiang Wen

http://www.w3.org/2001/XMLSchema#string

Suzanne Z Powell

http://www.w3.org/2001/XMLSchema#string

Weihua Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

FOXP3+ regulatory T cells in the human immune system

ALS: a disease of motor neurons and their nonneuronal neighbors

Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.

Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice.

Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.

Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis

Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue

CD4+ T cell plasticity-Th2 cells join the crowd.

CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS.

T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.

P304

64-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.201201544

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Stanley H Appel

P577

2012-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233396176

http://www.w3.org/2001/XMLSchema#string

P698

23143995

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

3569654

http://www.w3.org/2001/XMLSchema#string